Retinoids’ Extraordinary Potential
August 17, 2017
Lorraine Gudas and her team investigate the irrefutable pharmacological potential of retinoids for treating cancers, diabetes, and other disorders.
The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.